Safety and efficacy of Nordic walking training in adult patients with asthma: a pilot randomised controlled trial with a mixed-methods approach

Vista sencilla de ítem
dc.contributor.authorVilanova Pereira, María
dc.contributor.authorJácome, C.
dc.contributor.authorBarral Fernández, Margarita
dc.contributor.authorGuerra Fandiño, Verónica
dc.contributor.authorZumeta Olaskoaga, Lore
dc.contributor.authorRial Prado, Manuel Jorge
dc.contributor.authorBlanco Aparicio, Marina
dc.contributor.authorGarrido Victorino, David
dc.contributor.authorLosada García, Iria
dc.contributor.authorArbillaga Etxarri, Ane
dc.contributor.authorFontán García Boente, L.
dc.contributor.authorVaes, Anouk W
dc.contributor.authorDeng, Qichen
dc.contributor.authorSpruit, Martijn A.
dc.contributor.authorLista Paz, Ana
dc.date.accessioned2026-05-04T10:02:05Z
dc.date.available2026-05-04T10:02:05Z
dc.date.issued2026-05-01
dc.date.updated2026-05-04T10:02:05Z
dc.description.abstractIntroduction: Nordic walking (NW) may benefit patients with asthma by enhancing functional exercise capacity and reducing symptoms, though evidence remains limited. This study assessed NW safety and effects in patients with asthma and explored their experiences. Methods: A mixed-method two-arm, parallel, pilot randomised controlled trial was conducted in A Coruña between (July 2021 - May 2025). Adults with asthma attended three educational sessions before randomization to NW group (NWG) or control group (CG). The NWG performed NW 3 days/week, during eight weeks, at 70-85% of maximum heart rate. Both groups maintained usual care. The primary outcome was the 6-min walking distance (6MWD). Secondary outcomes included 1-min Sit-to-Stand Test, physical activity (PA) and adverse events. Experiences were explored through individual interviews. Results: Thirty-four participants with asthma (mean ± SD age 45.4 ± 11.4 years, 82.4% female) were randomly allocated to NWG (n = 17) or CG (n = 17). NW adherence was 80.1 + 16.1%. No adverse effects occurred. Post-intervention, the NWG increased 6MWD by 12.1 ± 30.4 m (m) (P = .119), whereas the CG decreased by 13.6 ± 41.3m (P = .193), without significant between-groups differences (P = .067; Cohen's d = 0.7; 95% confidence interval (CI) 0.-1.3). The NWG spent more time in vigorous PA compared to CG (P = .016, r = 0.4, 95% CI 0.8-52.4). All NWG participants recommended NW, citing health improvements and finding it manageable, comfortable, and implementable. Conclusion: Although between-groups differences were not significant, NW was safe, feasible, accessible and perceived as beneficial by individuals with asthma. Given the demonstrated safety, future studies should tailor NW intensity to fitness and asthma control levels.en
dc.description.sponsorshipThis trial was partially funded by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), and the Official College of Physiotherapists from Galicia (CoFiGa). The University of A Coruna ˜ and Decathlon® donated part of the walking poles. M.V.P. received a grant from Programa de axudas para estadías predoutorais de investigacion ´ INDITEX-UDC 2025 (Grant Program for PreDoctoral Research Stays INDITEX–UDC 2025) to do a research stay at CIROen
dc.identifier.citationVilanova-Pereira, M., Jácome, C., Barral-Fernández, M., Guerra-Fandiño, V., Zumeta-Olaskoaga, L., Rial-Prado, M. J., Blanco-Aparicio, M., Garrido-Victorino, D., Losada-García, I., Arbillaga-Etxarri, A., García-Boente, L. F., Vaes, A. W., Deng, Q., Spruit, M. A., & Lista-Paz, A. (2026). Safety and efficacy of Nordic walking training in adult patients with asthma: a pilot randomised controlled trial with a mixed-methods approach. Respiratory Medicine, 256. https://doi.org/10.1016/J.RMED.2026.108817
dc.identifier.doi10.1016/J.RMED.2026.108817
dc.identifier.eissn1532-3064
dc.identifier.issn0954-6111
dc.identifier.urihttps://hdl.handle.net/20.500.14454/5858
dc.language.isoeng
dc.publisherW.B. Saunders Ltd
dc.rights© 2026 The Authors
dc.titleSafety and efficacy of Nordic walking training in adult patients with asthma: a pilot randomised controlled trial with a mixed-methods approachen
dc.typejournal article
dcterms.accessRightsopen access
oaire.citation.titleRespiratory Medicine
oaire.citation.volume256
oaire.licenseConditionhttps://creativecommons.org/licenses/by-nc-nd/4.0/
oaire.versionVoR
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
vilanova_safety_2026.pdf
Tamaño:
1.5 MB
Formato:
Adobe Portable Document Format
Descargar
Colecciones
Artículos